Hinge Health (NYSE:HNGE) CEO Daniel Antonio Perez Sells 4,100 Shares of Company Stock

Key Points

• CEO Daniel Antonio Perez sold 4,100 Hinge Health shares at an average price of $100.20, generating $410,820. The Rule 10b5-1 transaction cut his direct ownership by 50% to 4,100 shares.
• Hinge Health shares opened at $97.52, near their 52-week high of $100.36, while the company reported $212.82 million in quarterly revenue, up 53% year over year, and EPS of $0.59 versus analyst estimates of $0.28.
• Analyst sentiment remains positive, with a consensus “Moderate Buy” rating and an average price target of $105.33; several major institutional investors also increased their positions.

Hinge Health Inc. (NYSE:HNGE - Get Free Report) CEO Daniel Perez sold 4,100 shares of Hinge Health stock in a transaction on Tuesday, October 6th. The shares were sold at an average price of $100.20, for a total value of $410,820.00. Following the completion of the sale, the chief executive officer directly owned 4,100 shares of the company's stock, valued at $410,820. This trade represents a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Daniel Antonio Perez also recently made the following trade(s):

• On Thursday, September 10th, Daniel Perez sold 150,000 shares of Hinge Health stock. The shares were sold at an average price of $89.44, for a total value of $13,416,000.00.
• On Thursday, September 10th, Daniel Perez sold 100,000 shares of Hinge Health stock. The stock was sold at an average price of $89.45, for a total value of $8,945,000.00.

Hinge Health Trading Down 0.8%

Shares of NYSE:HNGE opened at $97.52 on Thursday. Hinge Health Inc. has a 1-year low of $30.08 and a 1-year high of $100.36. The stock has a market capitalization of $7.87 billion, a P/E ratio of 76.18 and a beta of 1.37. The business has a 50-day moving average price of $90.23 and a two-hundred day moving average price of $70.59.

Hinge Health (NYSE:HNGE - Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.59 EPS for the quarter, topping analysts' consensus estimates of $0.28 by $0.31. The firm had revenue of $212.82 million during the quarter. Hinge Health had a net margin of 15.15% and a return on equity of 51.60%. Hinge Health's revenue was up 53.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.59 EPS. As a group, equities analysts predict that Hinge Health Inc. will post 1.25 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Barclays raised their price target on shares of Hinge Health from $97.00 to $100.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 5th. Weiss Ratings upgraded shares of Hinge Health from a "sell (d-)" rating to a "hold (c)" rating in a report on Tuesday, September 22nd. KeyCorp raised their target price on shares of Hinge Health from $90.00 to $125.00 and gave the company an "overweight" rating in a research report on Monday, July 13th. Wells Fargo & Company boosted their price target on shares of Hinge Health from $90.00 to $103.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 5th. Finally, Stifel Nicolaus increased their price objective on shares of Hinge Health from $96.00 to $115.00 and gave the stock a "buy" rating in a research note on Tuesday, September 8th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $105.33.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. 11.2 Capital Management LLC bought a new position in Hinge Health during the 2nd quarter worth $204,566,531. Wellington Management Group LLP lifted its position in shares of Hinge Health by 169.7% during the 2nd quarter. Wellington Management Group LLP now owns 1,205,584 shares of the company's stock valued at $100,063,000 after acquiring an additional 758,594 shares during the period. Arrowstreet Capital Limited Partnership grew its holdings in shares of Hinge Health by 225.7% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 1,163,187 shares of the company's stock worth $44,852,000 after purchasing an additional 806,007 shares in the last quarter. Alkeon Capital Management LLC increased its position in shares of Hinge Health by 110.4% in the fourth quarter. Alkeon Capital Management LLC now owns 791,104 shares of the company's stock worth $36,747,000 after purchasing an additional 415,093 shares during the period. Finally, Estuary Capital Management LP acquired a new stake in Hinge Health during the first quarter worth about $15,201,000.

About Hinge Health

Hinge Health, Inc is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care designed to help members manage pain, improve mobility and avoid or delay more invasive treatments.

Its platform combines a mobile application, motion-sensing technology, personalized exercise therapy, education and support from a care team that may include clinical specialists. Hinge Health offers programs for conditions such as chronic back pain, knee pain and other common MSK issues, with services generally provided through employers, health plans and other healthcare organizations.

Hinge Health was founded in 2015 and is headquartered in San Francisco, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.